Teva Is Approved to Purchase Allergan’s Generics Business

Thursday, July 28, 2016 - 07:21 in Mathematics & Economics

The pharmaceutical company won antitrust approval after agreeing to sell rights and assets related to 79 generic drugs to rival firms.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net